儿童扁桃体癌:全国与机构视角
基于SEER 18数据库1973至2013年数据,儿童扁桃体癌年龄调整发病率为0.021/10万/年,以非霍奇金淋巴瘤为主(84.1%)。机构回顾性分析5例患儿均表现为≤12周内扁桃体快速增大,部分伴显著扁桃体不对称或颈部淋巴结肿大。
要点
- 儿童扁桃体癌罕见,非霍奇金淋巴瘤占绝大多数。
- 扁桃体快速增大≤12周、显著不对称或颈部淋巴结肿大时需高度怀疑。
- Brodsky量表扁桃体大小差异≥2度提示显著不对称。
核心结论
- 儿童扁桃体癌罕见,非霍奇金淋巴瘤是主要病理类型。
- 对扁桃体快速增大、显著不对称或伴颈部淋巴结肿大的儿童应保持高度怀疑。
研究设计与样本
- 利用SEER 18数据库(1973-2013年)分析儿童扁桃体癌发病率。
- 对2013年1月至2017年1月诊断的扁桃体恶性肿瘤患儿进行机构回顾性病历回顾。
主要发现
- SEER 18数据库纳入138例儿童扁桃体癌患者,年龄调整发病率为0.021/10万/年。
- 多数病例为单侧(79.7%),男性及白人占优势。
- 非霍奇金淋巴瘤占84.1%,其中伯基特淋巴瘤31.1%、弥漫大B细胞淋巴瘤26.8%、滤泡性淋巴瘤10.1%。
- 机构回顾发现5例扁桃体恶性肿瘤患者,多数亦为非霍奇金淋巴瘤,全部有≤12周扁桃体快速增大史。
- 4例存在显著扁桃体不对称,4例伴显著颈部淋巴结肿大。
关键数值与推荐
- 扁桃体显著不对称定义为Brodsky量表扁桃体大小差异≥2度。
- 扁桃体快速增大指病程≤12周。
临床怎么用
- 对儿童扁桃体快速增大、Brodsky量表差异≥2度或伴显著颈部淋巴结肿大者,应警惕恶性肿瘤并及时评估。
局限性
- 机构回顾样本量小(5例), supplementary qualitative information有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate childhood and adolescent tonsil cancer incidence and to identify the clinical characteristics indicative of those patients who would benefit from urgent operative intervention. STUDY DESIGN: The Surveillance, Epidemiology and End Results 18 database, inclusive of national cancer statistics from 1973 to 2013, provided quantitative tonsil cancer incidence data. An institutional retrospective chart review of pediatric patients diagnosed with tonsil malignancy from January 2013 to January 2017 identified supplementary qualitative clinical presentation information. RESULTS: The Surveillance, Epidemiology and End Results 18 database included 138 pediatric patients with tonsil cancer with an age-adjusted incidence rate of 0.021/100 000 patients per year. The majority of cases were unilateral (79.7%), and there was both a male and Caucasian predominance. Non-Hodgkin lymphoma (84.1%) was the most common malignancy, of which Burkitt lymphoma (31.1%), diffuse large B-cell lymphoma (26.8%), and follicular lymphoma (10.1%) were the most common subtypes. Five tonsillar malignancy patients were identified upon institutional chart review. The majority likewise had non-Hodgkin lymphoma and all shared a history of rapid tonsillar enlargement over ≤12 weeks. Significant tonsillar asymmetry was present in 4 patients. Four patients additionally exhibited prominent cervical lymphadenopathy. CONCLUSIONS: Pediatric tonsil cancer is rare, with non-Hodgkin lymphoma accounting for the majority of pediatric tonsillar malignancies. A high index of suspicion is appropriate in children who present with relatively rapid tonsil enlargement, tonsillar asymmetry characterized by a difference in tonsillar size of ≥2 degrees on the Brodsky scale, or concurrent prominent cervical lymphadenopathy.
引用
- Adil EA, Medina G, Cunningham MJ, et al. Pediatric Tonsil Cancer: A National and Institutional Perspective. J Pediatr. 2018. PMID: 29571929. doi:10.1016/j.jpeds.2018.01.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。